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Abstract: Mesenchymal stem cells are being used increasingly in cell-based therapies. Adipose tissue is an important source of
mesenchymal stem cells and is also routinely used in research on lipid metabolism and obesity. Their high expansion potential and
the ease of isolation make these cells an attractive cell source for regenerative therapies. The objective of this review is to give detailed
information about the isolation, expansion, and clinical use of these cells in veterinary medicine.
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1. Introduction
Adipose tissue is found in all vertebrates including
humans. Adipose tissue is a special type of connective
tissue in which adipocytes predominate. According to
the anatomical region of the body, either dense or loose
connective tissue is found in between adipose cells. This
connective tissue is composed of fibroblasts, connective
tissue fibers, blood and lymphatic vessels, and nerves
(1). One gram of adipose tissue contains approximately
350,000 multipotent cells referred to as preadipocytes and
approximately 5000 adipose tissue-derived stem cells. This
number is 35-fold greater than the number of stem cells
available in bone marrow. In other words, adipose tissue
contains a much higher number of stem cells than bone
marrow (2,3). Furthermore, recent research suggests that
obesity, also known as the excessive accumulation of fat in
the body, could be a stem cell disease (4,5). Adenovirus-36
has been shown to have an effect on stem cells and convert
them into adipocytes (4,5). In veterinary medicine, stem
cell treatment is performed with the use of not only
adipose tissue-derived stem cells, but also bone marrowderived stem cells. These cells are used mostly for the
treatment of tendon and ligament injuries in horses and
muscle and skeletal diseases in dogs, as well as for cartilage
and joint damage (6,7). In a previously conducted study,
the adipogenic differentiation and expansion potential
of adipose tissue-derived stem cells was compared using
tissue samples taken from young and old dogs. It was
concluded that stem cells isolated from young dogs had a
potential of rapid expansion (8). A recent review supported
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the suggestion that adipose-derived stem cells from aging
and ailing donors have a diminished proliferative and
proangiogenic potential due to hypoxic conditions (9).
In clinical cell-based therapies, the new trend is
to use the own stem cells of each organ (10). The fine
structure and differentiation features of bone marrowderived mesenchymal stem cells have been investigated by
transmission electron microscopy and scanning electron
microscopy, and it has been found that these cells are in
continuous communication, which is very important for
signaling (11,12).
Adipose tissue is an important source of multipotent
mesenchymal stem cells. As we know, five different types
of adipose tissue exist. These are bone marrow, brown,
mammary, mechanical, and white adipose tissue. Each
source has a distinct biological function. Bone marrow
adipose tissue serves as an energy reservoir and cytokine
source for osteogenic and hematopoietic events. Brown
adipose tissue generates heat, has an abundant number of
mitochondria, and is available around major organs (heart,
kidney, aorta, gonads) in newborn infants but disappears
as the body matures. Mammary adipose tissue provides
nutrients and energy during lactation. Mechanical adipose
depots, such as retroorbital and palmar fat pads, provide
support to the eyes, hands, and other critical structures.
White adipose tissue provides energy to the body and
protects the organs from damage (13).
Due to ethical limitations concerning the source
of embryonic stem cells, studies mainly focus on
mesenchymal stem cells. The clinical use of adipose
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tissue-derived mesenchymal cells for treatment is rather
common. Given their therapeutic use, the safety, efficacy,
reproducibility, and quality of these cells are of importance.
Therefore, isolation and cell expansion protocols have
been developed for adipose tissue-derived mesenchymal
cells. Adipose tissue-derived stem cells are considered as
the most readily available type of stem cells, which are
characterized by high reproducibility and a high potential
of differentiation into bone, muscle, and cartilage cells,
and they can be used in allogeneic stem cell treatment due
to their low immunogenicity (7,14,15).
The high prevalence of obesity today has led to an
increase in the number of studies carried out on brown
and white adipose tissue and fat metabolism. Owing
to its accessibility by surgery and its being a source of
mesenchymal stem cells, adipose tissue is an important
material for biomedical research. It has been reported that
adipose tissue-derived mesenchymal cells differentiate
into hepatocytes, osteoblasts, chondrocytes, myocytes,
and nerve cells, and even into adipocytes under favorable
conditions (14). Adipose tissue-derived stem cells are
similar to bone marrow-derived stem cells in that they
are mesenchymal stem cells, which adhere to plastic
and have a potential of differentiating into osteocytes,
chondrocytes, and adipocytes. For the characterization
of these cells, it is required that they express cell surface
markers CD105, CD73, and CD90. Recently the
International Federation for Adipose Therapeutics and
Science and the International Society for Cellular Therapy
proposed criteria for defining adipose tissue-derived cells.
Accordingly, the following surface markers should be
investigated: +CD13, CD29, CD44, CD90, and CD105
(>80%) and –CD14, CD31, CD45, CD144, and CD235a
(<2%) (9). CD34 is another marker that is of importance in
adipose tissue mesenchymal stem cells. Recent knowledge
about this marker includes its positivity in initial isolation
procedures of adipose tissue stem cells and negativity after
the first passage. At present it is not clear why this marker
disappears after the first passage. However, it is proven that
if a tissue is of adipose origin then this marker must be
present in the analysis (16). Prominent characteristics of
adipose tissue stem cells are immunomodulatory effects
such as regulating the function of T cells, antiinflammatory
cytokine expression, and time extension of the vitality of
allotransplants. Thus, adipose tissue stem cells have been
shown to suppress allogeneic lymphocytes in both in vitro
and in vivo conditions (15,17–19). Adipose tissue stem
cells do not retain MHC-II molecules, T helper cells and B
cells, CD80, CD86, or CD40 on the surface. Related to these
properties they are preferred in the treatment of immune
disorders such as Crohn disease. In addition, due to their
low immunogenicity, as well as in bone disease they can
also be used in allogeneic stem cell therapy (15,20). In cell-
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based therapy abundant numbers of cells are necessary.
Therefore, it is necessary to replicate the adipose tissue
stem cells prior to clinical application. Cells are passaged
in appropriate media for proliferation. During passage
of the cells to promote adhesion and proliferation fetal
bovine serum (FBS) is used. However, in clinical trials
in human medicine, animal-origin reagents are avoided
and allogeneic human serum (allo-HS), autogenic human
serum (auto-HS), and platelet-derived supplements were
investigated. Removal of animal-origin reagents provides
a high level of safety for the patient for cell transplant (15).
In adipose tissue stem cells, osteogenic, chondrogenic,
and adipogenic differentiation capacity are optimized,
and thus by providing differentiation protocols for each
activity capacity can be increased. One reason for the
decrease in the differentiation potential could be a decrease
of the adhesion surface of the cell. In addition, there is a
need for powerful nutrient-rich media for differentiation
(15,21,22). In adipose tissue stem cells, three-way
(trilinear) differentiation potential could be shown by oil
red O, Alcian blue, and von Kossa staining (15).
As the mesenchymal stem cell-related information
increases, the possibility of the use of these cells in
regenerative medicine increases. This is particularly true
for muscle and skeletal tissue; researchers have published
several reports of the use of mesenchymal stem cells in
orthopedic disorders.
Application of therapies based on autologous
cell transplantation is recommended due to the
multiple therapeutic potentials of these cells and low
immunogenicity. However, a large part of the proposed
therapy that requires prior replicating cell populations in
vitro could adversely affect the phenotype of the cell as it
moves slowly.
Single-surgery therapies, based on the isolation
of autologous mesenchymal stem cells and their
reintroduction into the site of injury within a short time
period, not only reduce costs but also shorten the recovery
period (23). Given their accessibility, their abundance
in adipose tissue, and their osteogenic, adipogenic, and
chondrogenic differentiation potential, human adipose
tissue-derived stem cells isolated from the stromal vascular
fraction of lipoaspirates are particularly suitable for use in
single-surgery strategies (24).
In a previous study (23), cells derived from the stromal
vascular fraction of adipose tissue were sorted on the basis
of the expression of liver/bone/kidney alkaline phosphatase
(ALP) levels with an aim to obtain cell subpopulations
with enhanced osteogenic potential. For this purpose, a
custom-designed molecular beacon for ALP was used
in combination with fluorescence-activated cell sorting.
High yields of cell subpopulations with a significantly
enhanced osteogenic potential, as compared to unsorted
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stromal vascular fraction cells and surface-marker sorted
adipose stem cells, were obtained with this approach.
Thus, cells offering an increased therapeutic potential for
bone regeneration therapy were obtained.
2. Isolation and differentiation protocols for adipose
stem cells
Adipose tissue is obtained from patients under general
anesthesia and is transported to the laboratory in sterile
tubes filled with Dulbecco’s modified Eagle medium
(DMEM) (Lonza, Belgium). The site of origin is also
important for the final cell yield. The inguinal, gluteal,
and extraabdominal fat tissue results are conflicting.
Intraabdominal cell isolation and expansion results
are more promising because they are more resistant to
apoptosis (9). In the laboratory, the tissues are cut into
small pieces (Figures 1A and 1B) in a sterile petri dish
under laminar flow, placed into T25 flasks, and expanded
by the explant culture method. Subsequently, the tissue
culture flasks are placed in a 5% CO2 incubator for 15 min
with the addition of 77% DMEM (Lonza) growth medium
containing 10% FBS (Lonza), followed by 2% L-glutamine
(Lonza), 1% penicillin, streptomycin, and amphotericin

Figure 1. Extraction of adipose tissue from dog (A, B).

(Biological Industries, Israel). For dissociation of the
tissue, collagenase treatment is another method of choice.
Compared to the explant culture method mentioned
above, the enzymatic treatment has higher cell yield but is
a more invasive way of isolating cells (3,9).
The medium is replaced every 3 days and cell growth
is observed under an inverted microscope (Olympus
CX45). Once 70% confluence is reached (Figure 2), the
cells are passaged at a ratio of 1:2, and prior to passaging
the number and viability of the cells are checked. At
the end of the third passage, the cells are subjected to
adipogenic (fat), osteogenic (bone), and chondrogenic
(cartilage) differentiation. For adipogenic differentiation,
adipocyte differentiation basal medium and supplements
(standard medium high-glucose DMEM (10% FBS), 0.5
mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone,
10 µg/mL insulin, 0.5 mM indomethacin (Sigma-Aldrich,
Switzerland)) (25); for osteogenic differentiation, osteocyte
differentiation basal medium (DMEM-LG, 0.05 mM
ascorbate-2-phosphate, 100 nM dexamethasone, and 10 mM
sodium β-glycerophosphate (Sigma-Aldrich)) (26); and for
chondrogenic differentiation, chondrocyte differentiation
basal medium (high-glucose DMEM containing 6.25 µg/
mL insulin-transferrin-selenious acid, 0.1 mM ascorbate2-phosphate, 10–7 M dexamethasone, 1.25 mg/mL bovine
serum albumin, 5000 IU/mL penicillin, 5000 µg/mL
streptomycin, 50 µg/mL ascorbate 2-phosphate, and 100
nM dexamethasone and 10 ng/mL human transforming
growth factor) (26) are used (Figure 3).
At the end of the third week, oil droplets, calcium
deposits in the extracellular matrix, and cartilaginous
differentiation are observed (24,27).
As a result, the development of safe and effective
in vitro methods that can be used for the isolation and
expansion of adipose tissue-derived stem cells is of critical
importance for the extension of cell-based therapies.

Figure 2. Appearance of a confluent flask.
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Figure 3. Chondrogenic differentiation (A), osteogenic differentiation (B), and adipogenic differentiation (C).

3. Conclusion
Both the ease of isolation of adipose tissue-derived
stem cells and the possibility of using allogenic adipose
tissue-derived stem cells in clinical cell-based treatments
will contribute to advances in future in vitro studies
on adipocytes and increase the knowledge available on
adipogenic differentiation. Preclinical safety assessment

studies need to be conducted for the use of allogeneic
adipose stem cells in clinical cell therapies. The sorting of
mesenchymal stem cells on the basis of gene expression
will bring about radical changes in conventional methods
and thereby contribute to a wide array of fields, from basic
sciences to clinical treatment.
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